F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
NYT > Health
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
تحميل تطبيق نبأ للآندرويد مجانا
اقرأ على الموقع الرسمي
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
تحميل تطبيق نبأ للآندرويد مجانا